SEC Form D · Amendment · filed June 29, 2020
Cingulate Therapeutics
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (32)
Arthur B. Straughn · Cordova, TNDirectorMatthew N. Brams · Houston, TXExec · DirectorCraig S. Gilgallon · Morristown, NJExecRaul R. Silva · Upper Grandview, NYExecShane J. Schaffer · Kansas City, KSExec · DirectorLouis G. Van Horn · Village of Loch Lloyd, MOExecPatrick J. Gallagher · Flanders, NJDirectorJeff J. Conroy · Norfolk, VADirectorLaurie A. Myers · Kansas City, MOExecJeff J. Hargroves · Kansas City, MODirectorPeter J. Werth · Woodbridge, CTDirectorJustin N. Lorino · New York, NYDirectorDavid Bartelme · Milwaukee, WIDirectorThomas J. Marusak · Albany, NYDirectorMarious 5. Sjulsen · New York, NYExecStelios R. Papadopoulos · San Diego, CAExecJames A. Henderson · New York, NYExec · DirectorBrent Adam · Milwaukee, WIDirectorRyan Pineda · Las Vegas, NVExec · DirectorJeff Kellam · Longview, TXDirectorWilliam P. Phelan · Albany, NYExecGeorge A. Overholser · KIRKLAND, WADirectorJohn H. Cox · Schaumburg, ILExecAlan Kelley · Durham, NCDirectorRonnie Wallace · Rome, GAExec · DirectorBryan Kelley · Rome, GAExecPaul R. Marcus · Boston, MAExecChris S. Varin · Colchester, VTDirectorDana Arrighi · Orlando, FLDirectorDavid Scalzo · Orlando, FLExec · DirectorTerrance Berland · Orlando, FLDirectorLaurie A. Myers · Kansas City, MOExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗